International Journal Of Clinical Oncology

Journal Title：International Journal Of Clinical Oncology

The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.

《国际临床肿瘤学杂志》（IJCO）欢迎有关临床肿瘤学各个方面的原创研究论文，报告新颖且及时的研究结果。鼓励提交临床试验报告。如果实验研究与临床肿瘤学有明显相关性，也将接受。日本临床肿瘤学会的会员资格不是向该杂志投稿的先决条件。提交论文的前提是：论文内容未在其他地方全部或部分发表过；论文必须经过至少两名审稿人和编辑的同行评审，并且必须对语言和内容进行编辑修订；编辑负责论文的接受、拒绝和出版顺序。

International Journal Of Clinical Oncology创刊于1996年，由Springer Singapore出版商出版，收稿方向涵盖医学 - 肿瘤学全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 约2月 ，影响因子指数2.4，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。